Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.

Akira Shimada, Yasuhide Hayashi, Mizuho Ogasawara, Myoung ja Park, Masahiko Katoh, Hisanori Minakami, Toshiyuki Kitoh, Seiji Kojima, Keisei Kawa, Hirokazu Kimura

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Down syndrome (DS) patients are frequently complicated with infections, autoimmune phenomena and hematological disorders, including transient abnormal myelopoiesis (TAM) in infancy and acute megakaryoblastic leukaemia (AMKL) in later life. In this study, serum levels of cytokines from 23 TAM and 15 AMKL patients were examined using the highly sensitive microsphere fluorescence system. Statistical differences between DS neonates with or without TAM were found in IL-1beta [median 7.0 pg/ml (0.34-271.6) verses 0.05 pg/ml (0.0-2.4), p=0.034], TNF-alpha [8.11 pg/ml (0.1-253.0) verses 0.41 pg/ml (0.1-1.5), p=0.041], and IFN-gamma [20.0 pg/ml (0.14-406.3) verses 1.5 pg/ml (0.14-5.79), p=0.036]. Moreover, abnormal inflammatory cytokinemia was also found in myelodysplastic syndrome (MDS) and AMKL with DS. These abnormal cytokinemia may have a role in the pathophysiology of TAM, MDS and AMKL in DS, especially in liver fibrosis or myelofibrosis.

Original languageEnglish
Pages (from-to)1199-1203
Number of pages5
JournalLeukemia Research
Volume31
Issue number9
DOIs
Publication statusPublished - Sep 2007
Externally publishedYes

Fingerprint

Leukemia, Megakaryoblastic, Acute
Down Syndrome
Myelodysplastic Syndromes
Primary Myelofibrosis
Microspheres
Liver Cirrhosis
Tumor Necrosis Factor-alpha
Fluorescence
Newborn Infant
Cytokines
Transient Myeloproliferative Syndrome
Infection
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders. / Shimada, Akira; Hayashi, Yasuhide; Ogasawara, Mizuho; Park, Myoung ja; Katoh, Masahiko; Minakami, Hisanori; Kitoh, Toshiyuki; Kojima, Seiji; Kawa, Keisei; Kimura, Hirokazu.

In: Leukemia Research, Vol. 31, No. 9, 09.2007, p. 1199-1203.

Research output: Contribution to journalArticle

Shimada, A, Hayashi, Y, Ogasawara, M, Park, MJ, Katoh, M, Minakami, H, Kitoh, T, Kojima, S, Kawa, K & Kimura, H 2007, 'Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.', Leukemia Research, vol. 31, no. 9, pp. 1199-1203. https://doi.org/10.1016/j.leukres.2006.09.008
Shimada, Akira ; Hayashi, Yasuhide ; Ogasawara, Mizuho ; Park, Myoung ja ; Katoh, Masahiko ; Minakami, Hisanori ; Kitoh, Toshiyuki ; Kojima, Seiji ; Kawa, Keisei ; Kimura, Hirokazu. / Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders. In: Leukemia Research. 2007 ; Vol. 31, No. 9. pp. 1199-1203.
@article{423d55f102bd4c8ba81c2363bf45dd41,
title = "Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.",
abstract = "Down syndrome (DS) patients are frequently complicated with infections, autoimmune phenomena and hematological disorders, including transient abnormal myelopoiesis (TAM) in infancy and acute megakaryoblastic leukaemia (AMKL) in later life. In this study, serum levels of cytokines from 23 TAM and 15 AMKL patients were examined using the highly sensitive microsphere fluorescence system. Statistical differences between DS neonates with or without TAM were found in IL-1beta [median 7.0 pg/ml (0.34-271.6) verses 0.05 pg/ml (0.0-2.4), p=0.034], TNF-alpha [8.11 pg/ml (0.1-253.0) verses 0.41 pg/ml (0.1-1.5), p=0.041], and IFN-gamma [20.0 pg/ml (0.14-406.3) verses 1.5 pg/ml (0.14-5.79), p=0.036]. Moreover, abnormal inflammatory cytokinemia was also found in myelodysplastic syndrome (MDS) and AMKL with DS. These abnormal cytokinemia may have a role in the pathophysiology of TAM, MDS and AMKL in DS, especially in liver fibrosis or myelofibrosis.",
author = "Akira Shimada and Yasuhide Hayashi and Mizuho Ogasawara and Park, {Myoung ja} and Masahiko Katoh and Hisanori Minakami and Toshiyuki Kitoh and Seiji Kojima and Keisei Kawa and Hirokazu Kimura",
year = "2007",
month = "9",
doi = "10.1016/j.leukres.2006.09.008",
language = "English",
volume = "31",
pages = "1199--1203",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.

AU - Shimada, Akira

AU - Hayashi, Yasuhide

AU - Ogasawara, Mizuho

AU - Park, Myoung ja

AU - Katoh, Masahiko

AU - Minakami, Hisanori

AU - Kitoh, Toshiyuki

AU - Kojima, Seiji

AU - Kawa, Keisei

AU - Kimura, Hirokazu

PY - 2007/9

Y1 - 2007/9

N2 - Down syndrome (DS) patients are frequently complicated with infections, autoimmune phenomena and hematological disorders, including transient abnormal myelopoiesis (TAM) in infancy and acute megakaryoblastic leukaemia (AMKL) in later life. In this study, serum levels of cytokines from 23 TAM and 15 AMKL patients were examined using the highly sensitive microsphere fluorescence system. Statistical differences between DS neonates with or without TAM were found in IL-1beta [median 7.0 pg/ml (0.34-271.6) verses 0.05 pg/ml (0.0-2.4), p=0.034], TNF-alpha [8.11 pg/ml (0.1-253.0) verses 0.41 pg/ml (0.1-1.5), p=0.041], and IFN-gamma [20.0 pg/ml (0.14-406.3) verses 1.5 pg/ml (0.14-5.79), p=0.036]. Moreover, abnormal inflammatory cytokinemia was also found in myelodysplastic syndrome (MDS) and AMKL with DS. These abnormal cytokinemia may have a role in the pathophysiology of TAM, MDS and AMKL in DS, especially in liver fibrosis or myelofibrosis.

AB - Down syndrome (DS) patients are frequently complicated with infections, autoimmune phenomena and hematological disorders, including transient abnormal myelopoiesis (TAM) in infancy and acute megakaryoblastic leukaemia (AMKL) in later life. In this study, serum levels of cytokines from 23 TAM and 15 AMKL patients were examined using the highly sensitive microsphere fluorescence system. Statistical differences between DS neonates with or without TAM were found in IL-1beta [median 7.0 pg/ml (0.34-271.6) verses 0.05 pg/ml (0.0-2.4), p=0.034], TNF-alpha [8.11 pg/ml (0.1-253.0) verses 0.41 pg/ml (0.1-1.5), p=0.041], and IFN-gamma [20.0 pg/ml (0.14-406.3) verses 1.5 pg/ml (0.14-5.79), p=0.036]. Moreover, abnormal inflammatory cytokinemia was also found in myelodysplastic syndrome (MDS) and AMKL with DS. These abnormal cytokinemia may have a role in the pathophysiology of TAM, MDS and AMKL in DS, especially in liver fibrosis or myelofibrosis.

UR - http://www.scopus.com/inward/record.url?scp=34548031666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548031666&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2006.09.008

DO - 10.1016/j.leukres.2006.09.008

M3 - Article

C2 - 17055049

AN - SCOPUS:34249898927

VL - 31

SP - 1199

EP - 1203

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 9

ER -